Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 28:15:1496160.
doi: 10.3389/fendo.2024.1496160. eCollection 2024.

Body composition and perceived stress levels in transgender individuals after one year of gender affirming hormone therapy

Affiliations

Body composition and perceived stress levels in transgender individuals after one year of gender affirming hormone therapy

Chiara Ceolin et al. Front Endocrinol (Lausanne). .

Abstract

Introduction: Higher stress levels are linked to increased body fat and decreased bone density, effects that can be exacerbated by lifestyle choices. This is particularly relevant for transgender and gender diverse (TGD) individuals, who often face additional stress from transphobia and social stigma. However, there is limited research on how stress affects body composition and bone health in TGD individuals, particularly in relation to gender-affirming hormone therapy (GAHT). This study examines the impact of perceived stress on these factors in TGD individuals before and after one year of GAHT, compared to a cisgender control group.

Methods: The study assessed 181 individuals, including 74 TGD participants (44 assigned female at birth [AFAB] and 30 assigned male at birth [AMAB]) and 107 controls (56 AFAB and 51 AMAB). Fifty-seven TGD participants completed follow-up one year after starting GAHT. Data collected included clinical history, blood tests, body composition, bone density, and quality of life assessments (Patient Health Questionnaire-9 [PHQ-9] and Perceived Stress Scale [PSS]).

Results: After one year of GAHT, TGD AFAB individuals showed a bone mineral density (BMD) similar to cisgender AMAB individuals, while TGD AMAB individuals' BMD remained significantly lower than cisgender controls. TGD AFAB individuals experienced increases in muscle strength (+8% from baseline), while TGD AMAB individuals showed a 24% increase in fat mass from baseline and an approximate 8% reduction in lean mass. PSS and PHQ scores, initially higher in TGD individuals, did not change significantly after one year of GAHT. A significant correlation was found between body fat percentage and PHQ and PSS scores at baseline and one year after GAHT, respectively.

Discussion: These findings reveal a complex relationship between GAHT, body composition, and perceived stress in TGD individuals, highlighting the need for further research on stress and health outcomes in this population.

Keywords: PHQ; PSS; body composition; bone mineral density; stress; transgender.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Changes in FMI, ASMMI, and muscle strength from baseline to one year after the initiation of GAHT. CIS, Cisgender; TGD, Transgender; AFAB, Assigned Female At Birth; AMAB, Assigned Male At Birth; FMI, Fat Mass Index; ASMMI, Appendicular Skeletal Muscle Mass Index; HGM, Handgrip max strength test. *p<0.05; ***p<0.001.
Figure 2
Figure 2
Correlations between PSS, fat, and FMI in the transgender population. FMI, Fat Mass Index; PSS, Perceived Stress Scale.

References

    1. Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, et al. . Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgender Heal. (2022) 23:S1–S259. doi: 10.1080/26895269.2022.2100644 - DOI - PMC - PubMed
    1. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. . Endocrine treatment of gender-dysphoric/gender-incongruent persons: An endocrine society∗clinical practice guideline. J Clin Endocrinol Metab. (2017) 102(11):3869–903. doi: 10.1210/jc.2017-01658 - DOI - PubMed
    1. Safer JD, Tangpricha V. Care of the transgender patient. Ann Intern Med. (2019) 171:ITC1–ITC16. doi: 10.7326/AITC201907020 - DOI - PubMed
    1. Giagulli VA, Castellana M, Pelusi C, Triggiani V. Androgens, body composition, and their metabolism based on sex. Front Horm Res. (2019) 53:18–32. doi: 10.1159/000494900 - DOI - PubMed
    1. Van Caenegem E, Taes Y, Wierckx K, Vandewalle S, Toye K, Kaufman JM, et al. . Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone. (2013) 54:92–7. doi: 10.1016/J.BONE.2013.01.039 - DOI - PubMed

LinkOut - more resources